Newsroom

Home / Newsroom / CBMG Approved to Commence Phase I Trial for C-CAR011 in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL)
29Nov

CBMG Approved to Commence Phase I Trial for C-CAR011 in Patients with Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Download Full Article as .PDF (Size: 162 kB)

This CBMG article was posted on 29 Nov 2016